S. M. de la Monte

Publications276
h-index67
Citations17,163
Highly Influential Citations576
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Wands
  • 507 Publications • 26,437 Citations
  • M. Tong
  • 94 Publications • 3,085 Citations
  • S. Monte
  • 132 Publications • 3,901 Citations
  • S. Craft
  • 323 Publications • 23,310 Citations
  • Publications
  • Influence
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
The neurodegeneration that occurs in sporadic Alzheimer's disease (AD) is consistently associated with a number of characteristic histopathological, molecular, and biochemical abnormalities,… Expand
  • 1,232
  • 66
  • PDF
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
Reduced glucose utilization and energy metabolism occur early in the course of Alzheimer's disease (AD) and correlate with impaired cognition. Glucose utilization and energy metabolism are regulated… Expand
  • 541
  • 34
Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed
Alzheimer's disease (AD) has characteristic histopathological, molecular, and biochemical abnormalities, including cell loss; abundant neurofibrillary tangles; dystrophic neurites; amyloid precursor… Expand
  • 693
  • 27
  • PDF
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
The cascade of Alzheimer's disease (AD) neurodegeneration is associated with persistent oxidative stress, mitochondrial dysfunction, impaired energy metabolism, and activation of pro-death signaling… Expand
  • 395
  • 27
Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
Alzheimer's disease (AD) is associated with major impairments in insulin and insulin-like growth factor (IGF) gene expression and signaling in the brain. These abnormalities increase with severity of… Expand
  • 288
  • 18
Sp110 Localizes to the PML-Sp100 Nuclear Body and May Function as a Nuclear Hormone Receptor Transcriptional Coactivator
ABSTRACT The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This structure is disrupted in a variety of human disorders including acute… Expand
  • 140
  • 16
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.
Interest in characterizing the role of impaired insulin actions in Alzheimer's disease (AD) and vascular dementia is growing exponentially. This review details what is currently known about insulin,… Expand
  • 471
  • 13
  • PDF
Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease
We performed morphometric analysis of five standardized coronal brain slices at anterior frontal (AF), caudate-putamen-accumbens (CAP), globus pallidus (GP), lateral geniculate nucleus (LGN), and… Expand
  • 392
  • 13
  • PDF
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.
BACKGROUND & AIMS The molecular pathogenesis of human hepatocellular carcinoma (HCC) is understood poorly. In some tumors, activation of the Wnt/beta-catenin pathway as a result of beta-catenin gene… Expand
  • 219
  • 13
Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations.
The development and maintenance of the vertebrate nervous system depends upon neuronal survival proteins known as neurotrophic factors. Nerve growth factor (NGF) remains the best characterized… Expand
  • 456
  • 10
...
1
2
3
4
5
...